n-methylaspartate has been researched along with Craniocerebral Trauma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilhelm, H | 1 |
| Biegon, A | 1 |
| Bass, R; Novikov, M; Shohami, E | 1 |
| Bullock, R; Reinert, MM | 1 |
| Juul, N; Marshall, LF; Marshall, SB; Morris, GF | 1 |
| Young, JS | 1 |
| Berrendero, F; Bittigau, P; Fernández-Ruiz, JJ; Hansen, HH; Hansen, HS; Ikonomidou, C; Lastres-Becker, I; Manzanares, J; Schmid, HH; Schmid, PC | 1 |
| Bullock, R | 1 |
2 review(s) available for n-methylaspartate and Craniocerebral Trauma
| Article | Year |
|---|---|
Clinical trials in head injury.
Topics: Arachidonic Acid; Barbiturates; Brain; Brain Ischemia; Calcium Channel Blockers; Clinical Trials as Topic; Craniocerebral Trauma; Free Radical Scavengers; Humans; Hypothermia, Induced; Injury Severity Score; N-Methylaspartate; Potassium Channel Blockers; Sodium Channel Blockers; Steroids | 1999 |
Introducing NMDA antagonists into clinical practice: why head injury trials?
Topics: Animals; Craniocerebral Trauma; Humans; N-Methylaspartate | 1992 |
1 trial(s) available for n-methylaspartate and Craniocerebral Trauma
| Article | Year |
|---|---|
Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cerebrovascular Circulation; Craniocerebral Trauma; Critical Care; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Glasgow Coma Scale; Humans; Injury Severity Score; Intracranial Hypertension; Male; Middle Aged; N-Methylaspartate; Pipecolic Acids; Prospective Studies; Risk; Treatment Outcome | 2000 |
5 other study(ies) available for n-methylaspartate and Craniocerebral Trauma
| Article | Year |
|---|---|
[Traumatic optic neuropathy].
Topics: Adrenal Cortex Hormones; Craniocerebral Trauma; Decompression, Surgical; Dose-Response Relationship, Drug; Facial Injuries; Humans; N-Methylaspartate; Nerve Compression Syndromes; Nerve Regeneration; Optic Disk; Optic Nerve Diseases; Optic Nerve Injuries; Prognosis; Pupil Disorders; Reflex, Pupillary; Tomography, X-Ray Computed | 2009 |
Neuroprotective activity of HU-211, a novel nonpsychotropic synthetic cannabinoid.
Topics: Animals; Brain Edema; Cells, Cultured; Craniocerebral Trauma; Dronabinol; Excitatory Amino Acid Antagonists; Gerbillinae; Hippocampus; Ischemic Attack, Transient; N-Methylaspartate; Neurons; Neuroprotective Agents; Neurotoxins; Pyramidal Tracts; Rats | 1995 |
Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.
Topics: Animals; Craniocerebral Trauma; Dronabinol; Male; Maze Learning; Memory; Motor Activity; N-Methylaspartate; Rats; Rats, Inbred Strains; Reaction Time; Time Factors | 1995 |
Cerebral perfusion pressure or intracranial pressure?
Topics: Blood Pressure; Cerebrovascular Circulation; Craniocerebral Trauma; Critical Care; Critical Pathways; Excitatory Amino Acid Antagonists; Humans; Intracranial Pressure; Multicenter Studies as Topic; N-Methylaspartate; Pipecolic Acids; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2000 |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.
Topics: Animals; Arachidonic Acids; Brain Concussion; Cannabinoid Receptor Modulators; Cerebral Cortex; Corpus Striatum; Craniocerebral Trauma; Dizocilpine Maleate; Endocannabinoids; Ethanolamines; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycerides; Male; N-Methylaspartate; Nerve Degeneration; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger | 2001 |